Association study of the G-protein β3 subunit C825T polymorphism with disease progression in patients with bladder cancer

被引：17
作者：
Eisenhardt A. [1 ]
Siffert W. [1 ]
Rosskopf D. [1 ]
Musch M. [2 ]
Mosters M. [2 ]
Roggenbuck U. [3 ]
Jöckel K.-H. [3 ]
Rübben H. [2 ]
Lümmen G. [2 ]
机构：
[1] Institut für Pharmakologie, Universitätsklinikum Essen, 45122 Essen
[2] Urologische Klinik, Universitätsklinikum Essen, 45122 Essen
[3] Institut für Medizinische Informatik, Biometrie und Epidemiologie, Universitätsklinikum Essen, 45122 Essen
来源：
World Journal of Urology | 2005年 / 23卷 / 4期
关键词：
Chemotaxis; Metastasis; Progression; Signal transduction; Transitional cell carcinoma;
D O I：
10.1007/s00345-005-0006-6
中图分类号：
学科分类号：
摘要：
The T-allele in the GNB3 C825T polymorphism has been associated with increased cell migration, a prerequisite for metastasis. In this study we investigated a potential association of the C825T-allele status and disease progression in patients with transitional cell carcinoma of the bladder (TCC). Genotyping of the GNB3 C825T polymorphism was performed in 389 patients with transitional cell carcinoma of the bladder and in 104 control subjects and clinical follow-up was worked up in 339 patients. Genotype distribution in 389 patients with bladder cancer was comparable to genotype distribution of the control group. There was no association of GNB3 C825T genotype with tumor stage or grade, but follow-up analysis in the subgroup of non-smokers revealed a shorter time to metastasis in 825T-allele carriers compared to individuals homozygous CC. The genotype of the GNB3 C825T polymorphism appears to influence the biological behavior of tumor disease in non-smoking TCC patients. © Springer-Verlag 2005.
引用
收藏
页码：279 / 286
页数：7
相关论文
共 26 条
  • [11] Muller A., Homey B., Soto H., Nianfeng G., Catron D., Buchanan M., McClanaghan T., Murphy E., Yuan W., Wagner S.N., Barrera J.L., Mohar A., Verastegui E., Zlotnik A., Involvement of chemokine receptors in breast cancer metastasis, Nature, 410, pp. 50-56, (2001)
  • [12] Neptune E.R., Bourne H.R., Receptors induce chemotaxis by releasing the betagamma subunit of Gi, not by activating Gq or Gs, Proc. Natl. Acad. Sci. USA, 94, pp. 14489-14494, (1997)
  • [13] Neptune E.R., Iiri T., Bourne H.R., Galphai is not required for chemotaxis mediated by Gi-coupled receptors, J. Biol. Chem., 274, pp. 2824-2828, (1999)
  • [14] Nilsson S., Ragnhammer P., Nygren P., Glimelius B., A systemic overview of chemotherapy effects in urothelial bladder cancer, Acta Oncol., 40, pp. 371-390, (2001)
  • [15] Raitanen M., Nieminen P., Tammela T., Impact of tumor grade, stage, number and size, and smoking and sex, on survival in patients with transitional cell carcinoma of the bladder, Br. J. Urol., 76, pp. 470-474, (1995)
  • [16] Rosskopf D., Koch K., Habich C., Geerdes J., Ludwig A., Wilhelms S., Jakobs K.H., Siffert W., Interaction of Gbeta3s, a splice variant of the G-protein Gbeta3, with Ggamma- and Galpha-proteins, Cell Signal, 15, pp. 479-488, (2003)
  • [17] Saad A., Hanbury D., McNicholas T., Boustead G., Woodman A., The early detection and diagnosis of bladder cancer: A critical review of the options, Eur. Urol., 39, pp. 619-633, (2001)
  • [18] Siffert W., Rosskopf D., Siffert G., Busch S., Moritz A., Erbel R., Sharma A.M., Ritz E., Wichmann H.E., Jakobs K.H., Horsthemke B., Association of a human G-protein β3 subunit variant with hypertension, Nat. Genet., 18, pp. 45-48, (1998)
  • [19] Siffert W., Forster P., Jockel K.H., Mvere D.A., Brinkmann B., Naber C., Crookes R., Du P., Heyns A., Epplen J.T., Fridey J., Freedman B.I., Muller N., Stolke D., Sharma A.M., Al Moutaery K., Grosse-Wilde H., Buerbaum B., Ehrlich T., Ahmad H.R., Horsthemke B., Du Toit E.D., Tiilikainen A., Ge J., Wang Y., Rosskopf D., Worldwide ethnic distribution of the G protein 3 subunit 825T allele and its association with obesity in Caucasian, Chinese, and black African individuals, J. Am. Soc. Nephrol., 1
  • [20] Skinner D.G., Lieskovsky G., Management of invasive and high-grade bladder cancer, Diagnosis and Management of Genitourinary Cancer, pp. 295-312, (1988)
123